$6.76
2.73%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.
ISIN
US8964383066
Symbol
TRIB

Trinity Biotech Plc Sponsored ADR Class A Stock price

$6.76
-2.95 30.38% 1M
-11.45 62.88% 6M
-16.97 71.51% YTD
-27.14 80.06% 1Y
-95.80 93.41% 3Y
-327.74 97.98% 5Y
-1,950.74 99.65% 10Y
-1,364.24 99.51% 20Y
Nasdaq, Closing price Fri, Sep 25 2026
-0.19 2.73%

Is Trinity Biotech Plc Sponsored ADR Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$4.5m
Enterprise Value
$137.3m
Net debt
$132.9m
Cash
$5.1m
Shares outstanding
386.8m
Valuation (TTM | estimate)
P/E
negative
P/S
0.1 | 0.1
EV/Sales
3.1 | 1.7
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-68.5%
Return on Equity
51.9%
ROCE
26.5%
ROIC
-13.8%
Debt/Equity
-1.9
Financials (TTM | estimate)
Revenue
$43.8m | $79.1m
EBITDA
$-6.9m
EBIT
$-9.5m
Net Income
$-37.4m
Free Cash Flow
$-12.2m
Growth (TTM | estimate)
Revenue
-28.9% | 80.5%
EBITDA
57.2%
EBIT
46.6%
Net Income
-17.6%
Free Cash Flow
14.8%
Margin
Gross
38.6%
EBITDA
-15.7%
EBIT
-21.8%
Net
-85.4%
Free Cash Flow
-27.8%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
2.5%
Employees
401
Rev per Employee
$110.0k

Trinity Biotech Plc Sponsored ADR Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Trinity Biotech Plc Sponsored ADR Class A forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Trinity Biotech Plc Sponsored ADR Class A forecast:

Buy
86%
Hold
14%

Financial data from Trinity Biotech Plc Sponsored ADR Class A

Dec '25
+/-
%
44 44
29% 29%
100%
- Direct Costs 27 27
33% 33%
61%
17 17
21% 21%
39%
- Selling and Administrative Expenses 24 24
26% 26%
56%
- Research and Development Expense 3.63 3.63
20% 20%
8%
-6.86 -6.86
57% 57%
-16%
- Depreciation and Amortization 2.68 2.68
43% 43%
6%
EBIT (Operating Income) EBIT -9.55 -9.55
47% 47%
-22%
Net Profit -37 -37
18% 18%
-85%

In millions USD.

Don't miss a Thing! We will send you all news about Trinity Biotech Plc Sponsored ADR Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trinity Biotech Plc Sponsored ADR Class A Stock News

Neutral
GlobeNewsWire
●
17 days ago
Trinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure   Data center power densities are increasing rapidly as AI workloads expand, creating greater thermal-management demands and interest in advanced liquid cooling solutions DUBLIN and WILSONVILLE, Ore., Sept. 09, 2026...
Neutral
GlobeNewsWire
●
29 days ago
- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress - PrePsia™ patent portfolio expands to nine granted U.S. and European patents - Company issues update on Nasdaq listing DUBLIN, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management s...
Neutral
GlobeNewsWire
●
about one month ago
-  Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular data center infrastructure - Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033 1 DUBLIN and WILSONVILLE, Ore., Aug. 17, 2026 (GLOBE NEWSWIRE) -- ...
More Trinity Biotech Plc Sponsored ADR Class A News

Company Profile

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Head office Ireland
CEO Mr. Gillard
Employees 401
Founded 1992
Website www.trinitybiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today